BackHemab Therapeutics Holdings Common Stock Overview

Hemab Therapeutics Holdings Common Stock Common Stock

Track Hemab Therapeutics Holdings Common Stock's common stock ($450M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Common Stock
$454.27M

Peer trimmed avg / median

Loading

Hemab Therapeutics Holdings Common Stock Common Stock History

Loading

Hemab Therapeutics Holdings Common Stock vs. peers: Common Stock Comparison

Loading

Hemab Therapeutics Holdings Common Stock Common Stock Growth (YoY per quarter)

Latest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.

Loading

Hemab Therapeutics Holdings Common Stock (COAG) FAQ

The latest common stock for COAG is $450M as of June 2026. Investors often review this figure alongside Hemab Therapeutics Holdings Common Stock's historical trend and sector peers before judging valuation or financial health.

A common stock figure of $450M for COAG is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting COAG's common stock ($450M), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Hemab Therapeutics Holdings Common Stock's common stock against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.